BR9812240A - Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica - Google Patents
Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênicaInfo
- Publication number
- BR9812240A BR9812240A BR9812240-1A BR9812240A BR9812240A BR 9812240 A BR9812240 A BR 9812240A BR 9812240 A BR9812240 A BR 9812240A BR 9812240 A BR9812240 A BR 9812240A
- Authority
- BR
- Brazil
- Prior art keywords
- rsv
- protein
- altered
- vertebrate
- composition
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 9
- 108090000623 proteins and genes Proteins 0.000 title abstract 9
- 239000000203 mixture Substances 0.000 title abstract 8
- 241000251539 Vertebrata <Metazoa> Species 0.000 title abstract 7
- 230000002163 immunogen Effects 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 102000039446 nucleic acids Human genes 0.000 title abstract 4
- 108020004707 nucleic acids Proteins 0.000 title abstract 4
- 150000007523 nucleic acids Chemical class 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 238000002255 vaccination Methods 0.000 title abstract 3
- 230000028993 immune response Effects 0.000 title abstract 2
- 230000006698 induction Effects 0.000 title abstract 2
- -1 use of it Proteins 0.000 title abstract 2
- 238000010276 construction Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108091006027 G proteins Proteins 0.000 abstract 2
- 102000030782 GTP binding Human genes 0.000 abstract 2
- 108091000058 GTP-Binding Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000009732 pulmonary eosinophilia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
"PROTEìNA G ALTERADA OU POLIPEPTìDEO DO RSV, USO DA MESMA, MOLéCULA DE áCIDO NUCLEICO CODIFICANDO UMA PROTEìNA G ALTERADA OU UM POLIPEPTìDEO DO RSV, CONSTRUçãO DO áCIDO NUCLEICO, CéLULA HOSPEDEIRA RECOMBINANTE, PROCESSOS DE PRODUçãO DE UMA PROTEìNA G ALTERADA OU POLIPEPTìDEO DO RSV COMPOSIçãO IMUNOGêNICA, DE INDUçãO DE UMA RESPOSTA IMUNE EM UM VERTEBRADO, DE INIBIR A INDUçãO DO AUMENTO DA DOENçA APóS A VACINAçãO E SUBSEQUENTE INFECçãO DE UM VERTEBRADO COM O RSV E DE IMUNIZAçãO DE UM VERTEBRADO CONTRA O RSV, COMPOSIçãO DE VACINA, VACINA, E, COMPOSIçãO IMUNOGêNICA". é apresentada uma proteína G alterada ou parte desta de RSV que retém imunogenicidade e que, quando incorporada em uma composição imunogênica ou vacina e administrada a um vertebrado, não induz a um aumento na doença (por exemplo, inflamação pulmonar atípica tal como eosinofilia pulmonar) após subsequente infecção com RSV. Em uma modalidade particular, a proteína G alterada compreende uma alteração na região do aminoácido 184 ao aminoácido 198. As composições imunogênicas e vacinas compreendendo a proteína G RSV alterada, e opcionalmente compreendendo a proteína F RSV, são também apresentadas.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5968497P | 1997-09-19 | 1997-09-19 | |
| US8486398P | 1998-05-08 | 1998-05-08 | |
| PCT/US1998/019656 WO1999014334A1 (en) | 1997-09-19 | 1998-09-17 | Peptides derived from the attachment (g) protein of respiratory syncytial virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9812240A true BR9812240A (pt) | 2000-07-18 |
Family
ID=26739056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9812240-1A BR9812240A (pt) | 1997-09-19 | 1998-09-17 | Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1015595B1 (pt) |
| JP (1) | JP2001516583A (pt) |
| KR (1) | KR100550132B1 (pt) |
| CN (1) | CN1259422C (pt) |
| AT (1) | ATE287957T1 (pt) |
| AU (1) | AU751022B2 (pt) |
| BR (1) | BR9812240A (pt) |
| CA (1) | CA2302833C (pt) |
| CY (1) | CY1105010T1 (pt) |
| DE (1) | DE69828801T2 (pt) |
| ES (1) | ES2236946T3 (pt) |
| PT (1) | PT1015595E (pt) |
| WO (1) | WO1999014334A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60136381D1 (de) * | 2000-10-18 | 2008-12-11 | Us Gov Health & Human Serv | Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität |
| AUPR520201A0 (en) * | 2001-05-23 | 2001-06-14 | Commonwealth Scientific And Industrial Research Organisation | Antiviral compounds |
| NL1019228C1 (nl) | 2001-10-25 | 2003-04-28 | Duynstee Holding B V | Verbeterd gecombineerd ophang- en verlichtingssysteem voor bijvoorbeeld schilderijen e.d. |
| US6667327B2 (en) | 2002-02-04 | 2003-12-23 | Hoffmann-La Roche Inc. | Pyridine amido derivatives |
| DE10219219A1 (de) | 2002-04-29 | 2003-11-06 | Tampoflex Gmbh | Druckanlage |
| WO2004092207A2 (en) * | 2003-04-16 | 2004-10-28 | Algonomics N.V. | Respiratory syncytial virus (rsv) peptides |
| US7368537B2 (en) * | 2003-07-15 | 2008-05-06 | Id Biomedical Corporation Of Quebec | Subunit vaccine against respiratory syncytial virus infection |
| EP1680127B1 (en) | 2003-10-23 | 2008-10-15 | F. Hoffmann-La Roche Ag | Benzazepine derivatives as mao-b inhibitors |
| CA2569983A1 (en) * | 2004-06-30 | 2006-01-12 | Wyeth Holdings Corporation | Recombinant rsv strains with altered g protein |
| CA2684578A1 (en) * | 2007-03-21 | 2008-09-25 | Id Biomedical Corporation Of Quebec | Chimeric antigens |
| PL2222710T3 (pl) | 2007-12-24 | 2017-01-31 | Id Biomedical Corporation Of Quebec | Rekombinowane antygeny rsv |
| MX2012000036A (es) | 2009-06-24 | 2012-02-28 | Glaxosmithkline Biolog Sa | Vacuna. |
| PL2445526T3 (pl) | 2009-06-24 | 2017-08-31 | Glaxosmithkline Biologicals S.A. | Rekombinowane antygeny rsv |
| EP3178490B1 (en) | 2009-07-15 | 2022-04-20 | GlaxoSmithKline Biologicals S.A. | Rsv f protein compositions and methods for making same |
| KR101346197B1 (ko) * | 2009-07-17 | 2014-02-06 | 한림대학교 산학협력단 | 리포좀에 포집된 올리고뉴클레오타이드 및 에피토프를 포함하는 면역증강용 조성물 |
| AU2010279492B2 (en) | 2009-08-04 | 2015-04-09 | The Government Of The United States Of America, As Represented By The Secretary, Department Of The Health And Human Services, Centers For Disease Control And Prevention | Anti-RSV immunogens and methods of immunization |
| SI3275892T1 (sl) | 2011-05-13 | 2020-06-30 | Glaxosmithkline Biologicals S.A. | Prefuzijski RSV F antigeni |
| EP3956351A1 (en) * | 2019-04-18 | 2022-02-23 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Biological and synthetic molecules inhibiting respiratory syncytial virus infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2726577B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament |
| AU722494C (en) * | 1996-06-05 | 2007-03-29 | Commonwealth Scientific And Industrial Research Organisation | Viral peptides with structural homology to protein G of respiratory syncytial virus |
| AUPO026596A0 (en) * | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
-
1998
- 1998-09-17 JP JP2000511872A patent/JP2001516583A/ja not_active Withdrawn
- 1998-09-17 AT AT98949392T patent/ATE287957T1/de not_active IP Right Cessation
- 1998-09-17 PT PT98949392T patent/PT1015595E/pt unknown
- 1998-09-17 KR KR1020007002861A patent/KR100550132B1/ko not_active Expired - Fee Related
- 1998-09-17 AU AU95725/98A patent/AU751022B2/en not_active Ceased
- 1998-09-17 EP EP98949392A patent/EP1015595B1/en not_active Expired - Lifetime
- 1998-09-17 CN CNB988104911A patent/CN1259422C/zh not_active Expired - Fee Related
- 1998-09-17 ES ES98949392T patent/ES2236946T3/es not_active Expired - Lifetime
- 1998-09-17 CA CA002302833A patent/CA2302833C/en not_active Expired - Fee Related
- 1998-09-17 BR BR9812240-1A patent/BR9812240A/pt not_active Application Discontinuation
- 1998-09-17 WO PCT/US1998/019656 patent/WO1999014334A1/en not_active Ceased
- 1998-09-17 DE DE69828801T patent/DE69828801T2/de not_active Expired - Fee Related
-
2005
- 2005-02-24 CY CY20051100274T patent/CY1105010T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010030620A (ko) | 2001-04-16 |
| JP2001516583A (ja) | 2001-10-02 |
| KR100550132B1 (ko) | 2006-02-08 |
| CY1105010T1 (el) | 2010-03-03 |
| DE69828801D1 (de) | 2005-03-03 |
| DE69828801T2 (de) | 2005-07-14 |
| EP1015595A1 (en) | 2000-07-05 |
| ES2236946T3 (es) | 2005-07-16 |
| CA2302833A1 (en) | 1999-03-25 |
| CN1259422C (zh) | 2006-06-14 |
| CN1322250A (zh) | 2001-11-14 |
| EP1015595B1 (en) | 2005-01-26 |
| PT1015595E (pt) | 2005-05-31 |
| AU9572598A (en) | 1999-04-05 |
| CA2302833C (en) | 2007-05-08 |
| WO1999014334A1 (en) | 1999-03-25 |
| ATE287957T1 (de) | 2005-02-15 |
| AU751022B2 (en) | 2002-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9812240A (pt) | Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica | |
| DE69829668D1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
| HU226214B1 (en) | Vaccines with an ltb adjuvant | |
| BR9809445A (pt) | Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico. | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| JP2002525099A5 (pt) | ||
| EP1064024A4 (en) | VACCINES AGAINST CIRCOVIRUS INFECTIONS | |
| JP2003500040A5 (pt) | ||
| WO2001045639A3 (en) | Methods for protecting against lethal infection with bacillus anthracis | |
| ATE103297T1 (de) | Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea. | |
| JP2001516583A5 (pt) | ||
| FI924457A0 (fi) | Kompositioner och behandlingsfoerfarande foer lunginflammation i djur | |
| PT791063E (pt) | Proteina de transporte com efeito adjuvante, complexo imunogenico contendo a mesma, processo para a sua preparacao, sequencia nucleotidica e vacina | |
| KR970703428A (ko) | Hcmv 및 hsv로부터의 융합 당단백질(fusion glycoprotein from hcmv and hsv) | |
| KR890006253A (ko) | 가금류내의 E.coli septicaemia에 대한 백신 | |
| WO1999051188A3 (en) | A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof | |
| PE20010237A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS | |
| CA2516661A1 (en) | M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever | |
| AU700104B2 (en) | Prolactin as a vaccine adjuvant | |
| Menon et al. | Mycobacterial ESAT-6 protein enhances mouse IFN-γ responses to Mycoplasma hyopneumoniae P71 protein | |
| CA2277999A1 (en) | The 74 kilodalton outer membrane protein from moraxella catarrhalis | |
| DE69928947D1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| FR2809960B1 (fr) | Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante | |
| KR950704494A (ko) | 수두-대상포진 바이러스(vzv)에 대한 백신(vaccines against varicellazoster virus(vzv)) | |
| ATE305941T1 (de) | Impfstoff |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. |